Expand SMMT Menu
SMMT MENU

SMMT Stock Posts


Unusual Option Volume

SMMT Summit Therapeutics27.21+2.09 (+8.3%)

Summit Therapeutics trades 5,600 contracts. The company has the following event: Clinical Trial Collaboration to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate on Jun 15, 2026.
View Details...
SMMT Price Trending Up 8 Days in a Row

SMMT Summit Therapeutics25.20+0.05 (+0.2%)

Summit Therapeutics has traded higher again today, last trading at 25.20. Since this rise started on 9-Apr-2026, the stock has gained +34.0% in total. This is the longest positive trend in the last year for SMMT. View Stock Chart
Unusual Option Volume

SMMT Summit Therapeutics24.62-0.53 (-2.1%)

Summit Therapeutics trades 1,719 contracts. The company has the following event: Clinical Trial Collaboration to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate on Jun 15, 2026.
View Details...
Unusual Option Volume

SMMT Summit Therapeutics24.57+0.15 (+0.6%)

Summit Therapeutics trades 2,588 contracts. The company has the following event: Clinical Trial Collaboration to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate on Jun 15, 2026.
View Details...
Unusual Option Volume

SMMT Summit Therapeutics22.93+1.81 (+8.6%)

Summit Therapeutics trades 1,795 contracts. The company has the following event: Clinical Trial Collaboration to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate on Jun 15, 2026.
View Details...
Unusual Option Volume

SMMT Summit Therapeutics19.59+0.28 (+1.5%)

Summit Therapeutics trades 3,542 contracts. The company has the following event: Clinical Trial Collaboration to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate on Jun 15, 2026.
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes